Dengue fever
Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial
January 30, 2019Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases
Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …
MSD announced collaboration with Brazilian non-profit over development of dengue vaccine
December 13, 2018Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus
US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …
Sun Pharma to partner with ICGEB to develop novel Dengue treatment
May 4, 2016Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical
Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …
Setback for Sanofi dengue vaccine
September 13, 2012Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine
Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Medivir and Janssen in dengue fever research alliance
February 14, 2011Research and Development Dengue fever, Medivir
Medivir, the speciality pharma company focused on infectious diseases, it to collaborate with Janssen on discovering and developing new medicines …
Sanofi refocuses its French manufacturing capacity
April 1, 2010Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics
Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
